Pfizer shares data from experimental COVID-19 treatment with the FDA
Final data on Pfizer’s experimental treatment for COVID-19 has now been shared with the FDA. It’s part of the company’s application to authorize the pill for emergency use.
FDA
US expands COVID boosters to all adults, final hurdle ahead
The Food and Drug Administration has opened up COVID-19 booster shots to all adults, letting them choose another dose of either the Pfizer or Moderna vaccine. But there’s one more step: The Centers for Disease Control and Prevention must agree that even healthy young adults should get either a Pfizer or Moderna booster.
Moderna says the FDA needs more time to review its COVID-19 for teens
Moderna says the Food and Drug Administration needs more time to review its COVID-19 vaccine in teenagers. Moderna says the FDA wants to review the risk of heart inflammation in its vaccine in children and teens ages 12-17.
FDA paves way for Pfizer COVID-19 vaccinations in young kids
By Matthew Perrone and Lauran Neergaard
The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.
Survey finds most parents are hesitant to vaccinate their young kids against COVID-19
Health officials are closing in on a decision about Pfizer’s COVID-19 vaccine for kids ages 5-11, but a new survey shows significant hesitancy among parents to get young children vaccinated.
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters
By Matthew Perrone and Lauran Neergaard
U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
FDA says only 15% of seniors have gotten their COVID-19 booster shot
Only 15% of seniors have received a COVID-19 vaccine booster, according to the FDA.
FDA panel endorses lower-dose Moderna COVID shot for booster
By Lauran Neergaard and Matthew Perrone
U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
Health advisors to discuss boosters, mixing and matching COVID-19 vaccines
Vaccine advisors are set to discuss mixing and matching COVID-19 vaccines Friday.
Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines
By Lauran Neergaard and Matthew Perrone
With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn.
